Hu Hanguang, Ph.D.

Department:Medical Oncology

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Associate Chief Physician


Appointment

Clinical / Research Interests

Molecular mechanism and early warning of liver metastasis in colorectal cancer; drugs and targeted therapy for gastrointestinal and pancreatic malignancies; internal medicine therapy for neuroendocrine tumor.


Professional Highlights

Medicine and Health Science of Zhejiang Province, Second Prize, 2015

Professional Appointments

Member, Young Expert Committee, Chinese Society of Clinical Oncology (CSCO)

Vice Chairman, Youth Committee, Precision Diagnosis and Treatment of Tumor Committee, Zhejiang Anti-Cancer Association

Member, Youth Committee, Colorectal Cancer Committee, Zhejiang Anti-Cancer Association

Secretary, Tumor Metastasis Committee, Zhejiang Anti-Cancer Association

Youth Member, Neuroendocrine Tumor Branch, Chinese Medical Promotion Association


Education Experience

Research Summary

Publications

Ge, W.T., W. Cai, R. Bai, W.X. Hu, D.H. Wu, S. Zheng, and H.G. Hu. A novel 4-gene prognostic signature for hypermutated colorectal cancer. Cancer Management and Research, 2019. 11: p. 1985-1996.

Cai, W., W. Ge, Y. Yuan, K. Ding, Y. Tan, D. Wu, and H. Hu. A 10-year Population-based Study of the Differences between NECs and Carcinomas of the Esophagus in Terms of Clinicopathology and Survival. Journal of Cancer, 2019. 10(6): p. 1520-1527.

Liu, X., X. Fang, H. Hu, X. Fu, Y. Chen, and Y. Yuan. Efficacy of vemurafenib in a heavy smoker with BRAF-mutated lung adenocarcinoma: A case report and literature review. Mol Clin Oncol, 2018. 9(4): p. 472-476.

Cai, W., Y. Yuan, W.T. Ge, Y. Fan, X. Liu, D.H. Wu, and H.G. Hu. EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs. Journal of Cancer, 2018. 9(8): p. 1476-1485.

Cai, W., Y. Tan, W. Ge, K. Ding, and H. Hu. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study. Cancer Med, 2018. 7(6): p. 2699-2709.

Hu, H., W. Cai, S. Zheng, and W. Ge. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis. Cell Physiol Biochem, 2017. 44(4): p. 1485-1496.

Hu, H., H. Zhang, W. Ge, X. Liu, S. Loera, P. Chu, H. Chen, J. Peng, L. Zhou, S. Yu, Y. Yuan, S. Zhang, L. Lai, Y. Yen, and S. Zheng. Secreted Protein Acidic and Rich in Cysteines-like 1 Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers. Clin Cancer Res, 2012. 18(19): p. 5438-48.


Current Program

Find People

Search by Family Name

Find A Department

Search by Departments